Overexpression of eIF4E has been reported in cancer of the lung, breast, prostate, bladder, cervix, ovary, thyroid, and head and neck, as well as in hematologic neoplasms 19. Here, EIF4E is linked to hematopoietic and lymphoid system neoplasm.